Used in biomedical research to quantify levels of Cyclin-dependent Kinase 2 (CDK2) in human samples, this ELISA kit enables the detection and measurement of CDK2 protein concentrations in cell lysates, tissue extracts, or biological fluids. It is widely applied in studies related to cell cycle regulation, cancer progression, and drug development targeting kinase activity. Researchers use it to assess the impact of experimental treatments on CDK2 expression, particularly in oncology and pharmacology. The kit supports high-throughput screening and provides a reliable tool for monitoring changes in CDK2 levels under various physiological and pathological conditions.